08/14/2024
6:48 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
7:41 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
6:25 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
05/15/2024
4:19 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
05/01/2024
5:02 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:18 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
|
04/17/2024
8:38 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
| Form SC 13D/A | |
04/17/2024
7:21 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
4:21 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/15/2024
3:53 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:27 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B5 | |
04/07/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
3:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
04/01/2024
3:53 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B3 | |
03/29/2024
1:16 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/29/2024
9:39 AM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:00 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
03/26/2024
3:20 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:11 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
4:00 PM | KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
TRENARY C RUSSELL III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:24 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SC 13D/A | |
03/20/2024
4:20 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:14 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
3:43 PM | Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/08/2024
3:18 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
5:59 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
02/08/2024
6:00 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form ARS | |
01/24/2024
5:02 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
12/06/2023
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
7:12 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/20/2023
4:00 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/06/2023
7:16 AM | Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:13 PM | Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:14 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:15 PM | Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:05 PM | HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Has Trump Finally Gone Too Far? (Ad) Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks.
It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives.
But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars.
And here's the good news. Register For The Webinar To Discover |
10/05/2023
4:06 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:07 PM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Free OTLK Stock Alerts